• 12380 - Maurer
    Remibrutinib (LOU064) reduces the use of rescue medication in patients with chronic spontaneous urticaria: Findings from a Phase 2b study
    Marcus Maurer, John Reed, Petra Staubach, Karine Lheritier, Pauline Walsh, Vinayak Meti, Ivan Nikolaev, Sibylle Haemmerle, Ana Giménez-Arnau
    Poster Abstract

  • 12379 - Maurer
    Dupilumab improves urticaria signs and symptoms and quality of life in patients with chronic spontaneous urticaria (CSU)
    Kwatra SG, Yosipovitch G, Stander S, Guillemin I, Msihid J, Wiggins S, Levit NA, Bansal A, O’Malley JT, Bahloul D, Thomas R
    Poster Abstract

  • 12364 - McInnes
    Bimekizumab Efficacy and Safety in Biologic DMARD-Naïve Patients with Psoriatic Arthritis was Consistent With or Without Methotrexate: 52-Week Results from the Phase 3 Active Reference Study BE OPTIMAL
    Philip J. Mease, Yoshiya Tanaka, Frank Behrens, Laure Gossec, M. Elaine Husni,Lars E. Kristensen, Richard B. Warren, Barbara Ink, Rajan Bajracharya, Jason Coarse, Jason Eells, Alice B. Gottlieb
    Poster Abstract

  • 12381 - Mease
    Six-Month Persistence and Multi-Domain Effectiveness of Guselkumab in Adults With Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Mike Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
    Poster Abstract

  • 12382 - Menter
    Palmoplantar Psoriasis Complete Clearance Is Achieved Rapidly and Sustained With Ixekizumab Treatment in Adult and Pediatric Patients With Moderate-to-Severe Plaque Psoriasis
    M. Alan Menter, April W. Armstrong, Leon Kircik, Robert Gniadecki, Alyssa Garrelts, Kyoungah See, Missy McKean-Matthews, Jerry Bagel
    Poster Abstract

  • 12383 - Merola
    Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3 Randomized, Placebo-Controlled, Double-Blind DISCREET Study
    Joseph F. Merola, Lawrence Charles Parish, Lyn Guenther, Charles Lynde, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Shauna Jardon, Maria Paris, Mindy Chen, Kim Papp
    Poster Abstract

  • 12384 - Miller
    Key treatment attributes for moderate-to-severe atopic dermatitis: Preference results for patients and APPs from a US real-world, cross-sectional study
    Lauren Miller, Zach Dawson, Simran Marwaha, Evangeline Pierce, Peter Anderson, Lakshi Aldredge, Matthew Reynolds, Francine Phillips, Amber Reck Atwater, James Piercy, Sandri Johnson
    Poster Abstract

  • 12385 - Navarini
    Effisayil ON, an open-label, long-term extension study of spesolimab treatment in patients with generalized pustular psoriasis: Interim results for flare treatment
    Alexander A. Navarini, Siew Eng Choon, A. David Burden, Min Zheng, Akimichi Morita, Yuko Tanaka, Binqi Ye, Christian Thoma, Mark G. Lebwohl
    Poster Abstract

  • 12386 - Nickel
    Cost-effectiveness analysis of hypothetical novel treatment for moderate to severe plaque psoriasis: A case study in the United States using an adaptation of the ICER framework
    Katharina Nickel; Tim Ignacio; Sang Hee Park; Gijs van de Wetering; Lauren Seigel; Vardhaman Patel; Jashin J. Wu
    Poster Abstract

  • 12387 - Paller
    Clinically Important Benefits in Infants and Young Children With Moderate-to-Severe Atopic Dermatitis not Achieving IGA 0/1 After 16 Weeks of Dupilumab Treatment
    Amy S. Paller, Elaine C. Siegfried, Benjamin Lockshin, Amy Praestgaard, Brad Shumel, Randy Prescilla
    Poster Abstract

  • 12388 - Paller
    Tapinarof Cream 1% Once Daily for the Treatment of Extensive Atopic Dermatitis in Adolescents and Children: Outcomes from the 4-week Maximal Usage Trial
    Amy Paller, Adelaide Hebert, Philip M. Brown, Victoria Butners, Nancy Fitzgerald, Mercedes E. Gonzalez, Stephen C. Piscitelli
    Poster Abstract

  • 12389 - Palm
    HIGH SUBJECT SATISFACTION AND NATURAL-LOOKING RESULTS AFTER TREATMENT OF LATERAL CANTHAL LINES WITH RELABOTULINUMTOXINA, A NEW LIQUID BOTULINUMTOXIN (READY-2 PHASE III TRIAL)
    Melanie Palm, MD, MBA; Sherrif F Ibrahim, MD, PhD; David Bank, MD; Glynis Ablon, MD; Theda Kontis, MD; Sue Ellen Cox, MD; Jason K Rivers, MD; Lisa Grunebaum, MD; Mitchel P Goldman, MD; Shannon Humphrey, MD; Xiaoming Lin, RN, MSc; Alessandra Torres Nogueira, MD
    Poster Abstract

  • 12391 - Pandya
    Efficacy and Safety of Povorcitinib for Extensive Vitiligo: Results From a Double-Blinded, Placebo-Controlled, Dose-Ranging Phase 2b Study
    Amit G. Pandya, MD, Khaled Ezzedine, MD, PhD, Thierry Passeron, MD, PhD, Nanja van Geel, MD, PhD, Kurt Brown, MD, Leandro Santos, MSc, Lois Erskine, PhD, Kofi Wagya, PhD, Andrew Blauvelt, MD, MBA
    Poster Abstract

  • 12392 - Park
    Association of patient-reported disease burden and treatment switching among patients with plaque psoriasis on nonbiologic systemic therapy
    Sang Hee Park, Yichen Zhong, Adam Sima, Vardhaman Patel, Joe Zhuo, Carla Roberts-Toler, Brandon Becker, Sara Hovland, Bruce Strober
    Poster Abstract

  • 12393 - Patel
    Comparative Long-term Efficacy of Deucravacitinib and Adalimumab in the Treatment of Scalp Psoriasis: An Indirect Treatment Comparison
    Vardhaman Patel, Alexa Hetzel, Sang Hee Park, David Davidson, Malcolm Hogan, Ying Wu, Mirko Fillbrunn, Oscar Patterson-Lomba, Elyse Swallow, Jerry Bagel
    Poster Abstract

  • 12394 - Piliang
    Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
    Melissa Piliang, Charles Lynde, Brett King, Paradi Mirmirani, Rodney Sinclair, Robert Wolk, Samuel H. Zwillich, Helen Tran, Fan Zhang, Liza Takiya
    Poster Abstract

  • 12395 - Seigel
    An investigation of geographic disparities in health equity in the treatment of psoriasis
    Lauren Seigel; Sofia Shoaib; Keshia Maughn; Keith Wittstock; Samaneh Kalirai; Andrew Alexis
    Poster Abstract

  • 12396 - Senna
    Long-Term Efficacy of Baricitinib in Alopecia Areata: 104-Week Results from BRAVE-AA1 and BRAVE-AA2
    Maryanne Senna, Arash Mostaghimi, Manabu Ohyama, Rodney Sinclair, Yves Dutronc, Wen-Shuo Wu, Guanglei Yu, Chiara Chiasserini, Najwa Somani, Brett King
    Poster Abstract

  • 12397 - Siegfried
    A Case Series of Live Attenuated Vaccine Administration in Dupilumab-Treated Children With Atopic Dermatitis
    Elaine C. Siegfried, Lara Wine Lee, Jonathan M. Spergel, Sumeet Uppal, Anna Coleman, Brad Shumel, Randy Prescilla, Ashish Bansal, Sonya L. Cyr
    Poster Abstract

  • 12398 - Simpson
    Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)
    Eric Simpson, Lawrence Eichenfield, Melinda Gooderham, Mercedes E. Gonzalez, Adelaide Hebert, Kim Papp, Vimal H. Prajapati, David Krupa, Patrick Burnett, David Berk, Robert Higham
    Poster Abstract